The Valley Desk

NCT03052725 · Interventional trial

A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma

Overall registry status Terminated

Phase 3

Conditions Eosinophils, Asthma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov